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Summary
 
The mechanism of self-tolerance in the CD4
 
1
 
 T cell compartment was examined in a double
transgenic (Tg) model in which T cell receptor (TCR)-
 
a
 
/
 
b
 
 Tg mice with specificity for the
COOH-terminal peptide of moth cytochrome 
 
c
 
 in association with I-E
 
k
 
 were crossed with
antigen Tg mice. Partial deletion of cytochrome-reactive T cells in the thymus allowed some
self-specific CD4
 
1
 
 T cells to be selected into the peripheral T cell pool. Upon restimulation
with peptide in vitro, these cells upregulated interleukin (IL)-2 receptor but showed substan-
tially lower cytokine production and proliferation than cells from TCR Tg controls. Prolifera-
tion and cytokine production were restored to control levels by addition of saturating concen-
trations of IL-2, consistent with the original in vitro definition of T cell anergy. However, the
response of double Tg cells to superantigen stimulation in the absence of exogenous IL-2 was
indistinguishable from that of TCR Tg controls, indicating that these self-reactive cells were
not intrinsically hyporesponsive. Measurement of surface expression of Tg-encoded TCR 
 
a
 
and 
 
b
 
 chains revealed that cells from double Tg mice expressed the same amount of TCR-
 
b
 
 as
cells from TCR Tg controls, but only 50% of TCR-
 
a
 
, implying expression of more than one
 
a
 
 chain. Naive CD4
 
1
 
 T cells expressing both Tg-encoded and endogenous 
 
a
 
 chains also man-
 
ifested an anergic phenotype upon primary stimulation with cytochrome 
 
c 
 
in vitro, suggesting
that low avidity for antigen can produce an anergic phenotype in naive cells. The carboxy-
fluorescein diacetate succinimidyl ester cell division profiles in response to titered peptide 
 
6
 
IL-2 indicated that expression of IL-2 receptor correlated with peptide concentration but not
TCR level, whereas IL-2 production was profoundly affected by the twofold decrease in spe-
cific TCR expression. Addition of exogenous IL-2 recruited double Tg cells into division, re-
sulting in a pattern of cell division indistinguishable from that of controls. Thus, in this experi-
mental model, cells expressing more than one 
 
a
 
 chain escaped negative selection to a soluble
self-protein in the thymus and had an anergic phenotype indistinguishable from that of low
avidity naive cells. The data are consistent with the notion that avidity-mediated selection for
self-reactivity in the thymus may lead to the appearance of anergy within the peripheral, self-
reactive T cell repertoire, without invoking the induction of hyporesponsiveness to TCR-medi-
ated signals.
Key words: T cell receptor • double transgenic model • thymic deletion • T cell anergy • 
carboxyfluorescein diacetate succinimidyl ester labeling
 
S
 
elf-tolerance in the T cell compartment has been attrib-
uted to a combination of clonal deletion (negative
selection), clonal anergy, and clonal indifference, with reg-
ulatory mechanisms such as immune deviation and suppres-
sion superimposed on these cell-intrinsic processes. The
relative importance of these various mechanisms is thought
to depend on the site and avidity of interaction between T
cells and antigen. In the thymus, where developing T cells
are first subject to selection on the basis of TCR specificity,
clonal deletion is thought to be the primary mechanism of
tolerance induction (1–4). More recently, deletion has also
been shown to operate in the peripheral T cell compart-
ment (5–8).
On the other hand, the precise phenotype and signifi-
cance of T cell anergy remains more controversial. Origi-
nally the term was applied, by analogy with B cells (9), to a
state of induced hyporesponsiveness in Th1 cell clones
stimulated in vitro under conditions subsequently shown to
be associated with suboptimal CD28-mediated costimula-
tion (10–12). The anergic state was characterized by a de- 
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fect in IL-2 production and proliferation that could be re-
stored by addition of exogenous IL-2 (13). Subsequent use
of altered peptide ligand stimulation of T cell clones (14)
suggested that a “partial signal” in the presence of normal
costimulation could also result in an IL-2–sensitive anergic
phenotype.
The term anergy has also been applied to a number of in
vivo states of partial or complete unresponsiveness that
could not be explained solely on the basis of T cell deletion
(for review see reference 15). These states, often induced
by exposure to self-antigen, are commonly associated with
partial deletion. This has led to the suggestion that deletion,
anergy, and indifference represent the response to stimuli
of decreasing avidity (16), a model analogous to that postu-
lated for B cells (17, 18). Although anergic B cells show
clear evidence of prior antigen recognition in the form
of surface IgM downregulation (19), it remains unclear
whether T cells rendered anergic in vivo have already
made an abortive response to low avidity antigen (the in-
ductive model), or whether low avidity is, of itself, suffi-
cient to encode an anergic phenotype upon primary stimu-
lation of naive T cells in vitro (the selective model). In
support of the latter alternative, low avidity stimulation by
means of altered peptide ligands has been demonstrated to
stimulate naive T cells without inducing sufficient IL-2 to
drive proliferation (20). Moreover, in contrast to T cell
clones, naive T cells derived from TCR-
 
a/b
 
 Tg mice were
not rendered anergic in vitro by signaling through the
TCR alone (21).
We have examined this question in a double transgenic
(Tg)
 
1
 
 model in which TCR-
 
a/b
 
 Tg mice with specificity
for the COOH-terminal peptide of moth cytochrome 
 
c
 
(MCC) in association with I-E
 
k
 
 were crossed with antigen
Tg mice expressing a fusion protein of hen egg lysozyme
and cytochrome 
 
c
 
 (HELcyt) (22). In this experimental
model, deletion of Tg TCR
 
1
 
 cells occurs at the double
positive stage but is incomplete due to the very low level of
antigen expression (23). Previous studies have shown that
increasing the expression of the metallothionein-HELcyt
Tg by zinc induction leads to a significant increase in thy-
mic deletion of cytochrome-specific cells (Fazekas de St.
Groth, B., and M.M. Davis, manuscript in preparation),
suggesting that low avidity allows the exit of self-specific
CD4
 
1
 
 T cells into the periphery. However, double Tg
mice show no signs of autoimmunity and have a normal
life span, suggesting that the self-reactive T cells are func-
tionally tolerant in vivo. Examination of these cells showed
them to be fully responsive to superantigen but poorly re-
active to MCC/I-E
 
k
 
. This phenotype appeared to be due
to the expression of two or more TCR 
 
a
 
 chains paired
with the single TCR 
 
b
 
 chain, causing the cells to be of low
avidity for MCC/I-E
 
k
 
 but of high avidity for superantigen.
Dual TCR-
 
a
 
–expressing CD4
 
1
 
 T cells derived from naive
 
TCR Tg mice also displayed an anergic phenotype in re-
sponse to in vitro
 
 
 
stimulation by specific antigen. In other
words, low avidity was sufficient to produce an anergic
phenotype in vitro, in the absence of prior exposure to an-
tigen. Thus, in this experimental model, selective deletion
of high avidity cells in the thymus may fully account for the
anergic phenotype.
 
Materials and Methods
 
Mice
 
Tg mouse lines (Table I) and conventional inbred C57BL/6
(B6) and B10.BR mice were bred and housed under specific
pathogen–free conditions in the Centenary Institute animal house
facilities. All experiments were carried out with approval from
the University of Sydney Animal Ethics Committee. TCR Tg
mice specific for the COOH-terminal peptide of MCC
 
87–103
 
 in
the context of I-E
 
k
 
 were created using rearranged V
 
a
 
11 and V
 
b
 
3
chain genes from the 5C.C7 T cell clone (24) co-integrated and
expressed under the control of the endogenous 3
 
9
 
 
 
b
 
 chain en-
hancer (22, 25). Consistent with the phenotype of the previously
described cytochrome 
 
c
 
–specific 2B4 TCR Tg mice (26; termed
CY in this study), 
 
.
 
95% of peripheral T cells expressing the
5C.C7 TCR were selected into the CD4
 
1
 
 compartment. The
–D line (22) was established by microinjection of fertile C57BL/6J
eggs and maintained by backcrossing to B10.BR mice. Unless
otherwise stated, control TCR Tg mice were H-2
 
k/b
 
 F1 progeny
of –D (B10.BR) 
 
3 
 
C57BL/6 crosses and expressed the 5C.C7
TCR on 60–80% of CD4
 
1
 
 T cells. The remainder of the CD4
 
1
 
cells expressed an endogenously rearranged 
 
a
 
 chain paired with
the 5C.C7 
 
b
 
 chain. 5C.C7 single chain Tg mice (
 
a
 
 and 
 
b
 
,
 
termed O– and –V, respectively) have been described previously
(27). OV mice expressing both TCR chains were derived from
crosses of O– and –V single chain Tg mice. Two lines (Y– and
Z–) of antigen Tg mice expressing a fusion protein of HEL and
the COOH-terminal 24 amino acids of MCC as a soluble neo-
self-antigen (termed HELcyt) under the control of the murine
metallothionein promoter were crossed with –D to yield double
Tg mice termed YD or ZD (22, 23). In terms of phenotype and
function, these two lineages were equivalent, showing partial de-
letion at the CD4
 
1
 
CD8
 
1
 
 stage in the thymus, with 10–40% of
residual thymic and peripheral CD4
 
1
 
CD8
 
2
 
 
 
cells expressing the
5C.C7 TCR and the remainder expressing an endogenously re-
arranged 
 
a
 
 chain paired with the 5C.C7 
 
b
 
 chain.
 
Cell Preparation
 
The thymus and peripheral lymph nodes (pooled superficial
cervical, brachial, subscapular, and inguinal) were harvested asep-
tically into tissue culture medium (TCM, consisting of RPMI
1640 supplemented with 20 mM Hepes, 10 mM sodium bicar-
bonate, 50 mg/ml penicillin, 100 mg/ml streptomycin, 2 mM
glutamine, 50 
 
m
 
M 2-ME, and 10% FCS [Commonwealth Serum
Labs.]), and a single cell suspension made by pressing the organs
through an 80-gauge stainless steel sieve. Red cell lysis was per-
formed by suspending cells in 0.17 M Tris, 0.16 M ammonium
chloride for 3 min at room temperature. Enriching for mature
CD4 cells before in vitro culture or sorting was performed by in-
cubating cells with a mixture of mAbs specific for CD8 (3.168;
reference 28), HSA (J11d; reference 29), and B220 (RA3.3A1;
reference 30), followed by complement-mediated lysis (young
rabbit complement, C-six Labs.).
 
1
 
Abbreviations used in this paper:
 
 CFSE, carboxyfluorescein diacetate suc-
cinimidyl ester; HEL, hen egg lysozyme; MCC, moth cytochrome 
 
c
 
; PI,
propidium iodide; rhIL-2, recombinant human IL-2; SEA, Staphylococ-
cal enterotoxin A; TCM, tissue culture medium; Tg, transgenic. 
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Proliferation Assays
 
Individual cultures from four experimental mice and four con-
trols were routinely assayed in each experiment. Flow cytometric
analysis of each cell preparation was performed to allow calcula-
tion of the percentage of CD4
 
1
 
Tg 
 
a
 
1
 
b
 
1
 
 cells in each sample.
[
 
3
 
H]TdR incorporation assays with titered numbers of cells were
performed in quadruplicate with a starting concentration of 10
 
5
 
cells/well and five twofold dilutions. Irradiated (1,500 rads) syn-
geneic Tg-negative splenocytes were added at 10
 
5
 
 cells/well to
serve as a constant source of APCs. The four different stimulation
conditions used were: 1 
 
m
 
M MCC
 
87–103
 
 peptide, 50 U/ml re-
combinant human IL-2 (rhIL-2), MCC
 
87-103
 
 and rhIL-2 together,
and finally TCM alone. For peptide titrations, the number of re-
sponder cells was kept constant (10
 
5
 
/well), as was the number of
irradiated splenocytes (10
 
5
 
/well). MCC
 
87–103
 
 was titered in 10-
fold dilutions as indicated in the figures, and rhIL-2 (50 U/ml)
was added where indicated. All cultures were incubated at 37
 
8
 
C,
5% CO
 
2
 
 for 72 h, and pulsed with 0.5 
 
m
 
Ci [
 
3
 
H]TdR (ICN, Syd-
ney, Australia) in the final 6 h of culture. Before pulsing, 100 
 
m
 
l
of culture supernatant per well was collected for cytokine assays.
Cultures were harvested and [
 
3
 
H]TdR incorporation was esti-
mated in a beta scintillation counter.
 
CFSE Labeling
 
The intracellular fluorescent dye carboxyfluorescein diacetate
succinimidyl ester (CFSE, Molecular Probes) was used to label
cells (31) before in vitro culture. Thymus and lymph node cells
were resuspended at 5.0 
 
3 
 
10
 
7
 
/ml in serum-free RPMI 1640 and
incubated with 5 
 
m
 
M CFSE for 10 min at 37
 
8
 
C before washing
twice with ice cold RPMI/10% FCS. Bulk cultures were set up
in 24-well sterile tissue culture plates (Nunc) with 10
 
6
 
 responder
cells/well and an equivalent number of irradiated (1,500 rads)
splenocytes plus MCC
 
87–103
 
 (in 10-fold dilutions starting at 10 
 
m
 
M),
with or without rhIL-2 (50 U/ml) as indicated.
 
Cytokine Assays
 
IL-2 Bioassay.
 
 IL-2 was measured using the IL-2–dependent
CTLL cell line as previously described (32). The standard curve
was generated with a known quantity of rhIL-2 (Cetus Corp.).
The limit of detection was 0.03 U/ml.
 
IL-3 Bioassay.
 
 IL-3 was measured using the R6X cell line
(33). Serial dilutions of culture supernatant were added to 5 
 
3
 
10
 
3
 
 cells in 100 
 
m
 
l TCM and cultured for 42 h before pulsing
with [
 
3
 
H]TdR and harvesting as for T cell cultures. The standard
curve was generated using WEHI-3 conditioned medium (34).
1 U/ml was defined as the concentration resulting in 50% of maxi-
mal [
 
3
 
H]TdR incorporation. The limit of detection was 0.03 U/ml.
 
IFN-
 
g
 
 Capture ELISA.
 
 The assay, based on the method of
Adorini (35), was performed in 96-well flat-bottomed plates (Im-
muno Plate Maxisorp; Nunc) using mAb AN.18 (36) for capture,
and biotinylated XMG1.2 (37) followed by avidin-peroxidase
(Sigma Chemical Co.) for detection. The substrate was 3,3
 
9
 
-5,5
 
9
 
-
tetramethyl benzidine (Sigma Chemical Co.). The standard curve
was generated using a known quantity of recombinant murine
IFN-
 
g
 
 (supplied by J. Ruby, Australian National University,
Canberra, Australia). The limit of detection was 0.78 ng/ml.
 
IL-4 Capture ELISA.
 
 The assay was performed as for the
IFN-
 
g
 
 ELISA, using mAb 11B11 (38) as the capture Ab and
BVD6-biotin (PharMingen) for detection. The standard curve
was generated using recombinant murine IL-4 (a gift from P.D.
Hodgkin, Centenary Institute, Sydney, Australia, titered using the
HT-2 bioassay in which 1 U/ml was defined as the concentration
resulting in 50% of maximal [
 
3
 
H]TdR incorporation). The limit
of detection of the ELISA was 7.8 U/ml.
 
IL-10 and IL-5 Capture ELISAs.
 
 These assays were performed
using the mAb pairs SXC1 and biotinylated SXC4 (39) for detec-
tion of IL-10, and TRFK5 and biotinylated TRFK4 (40) for de-
tection of IL-5, followed by avidin-peroxidase (Sigma Chemical
Co.) and 2,2
 
9
 
-azino-bis(3-ethylbenzthiazoline-6-sulfonic) acid
(Sigma Chemical Co.) as substrate. The standard curve was gen-
erated with a known quantity of recombinant murine IL-10 or
IL-5, as appropriate. (Reagents for this assay were supplied by
P.D. Hodgkin). The limits of detection of the assays were 0.098
ng/ml for IL-10 and 31 ng/ml for IL-5.
 
Antibodies and Flow Cytometry
 
Tg T cells were identified using a five-color staining protocol,
including propidium iodide (PI) to exclude dead cells from analy-
sis. TCR V
 
a
 
11 was detected with biotinylated RR8.1 (41), fol-
lowed by Texas red–conjugated streptavidin (Molecular Probes).
TCR V
 
b
 
3 was stained with KJ25 (42) followed by fluorescein-
conjugated goat anti–hamster Ig (Caltag), or alternatively with
Texas red–conjugated goat anti–hamster Ig (Caltag) for samples
containing CFSE-labeled cells. CD8 was detected with 
 
a
 
CD8-
phycoerythrin (Caltag) and CD4 with 
 
a
 
CD4-allophycocyanin
(PharMingen) or 
 
a
 
CD4-phycoerythrin (PharMingen), as appro-
priate. In some experiments the protocol was modified to include
biotinylated anti–IL-2R
 
a
 
 Ab (PC61; reference 43) detected with
allophycocyanin-conjugated streptavidin (Molecular Probes). All
antibodies were diluted in PBS containing 5% FCS and 5 mM
sodium azide. Staining was performed in 96-well round-bot-
 
Table I. Summary of Genotypes and Phenotypes of Tg Mouse Lineages
Type of Tg line
Line and MHC
background Tg TCR chains Tg antigen
Tg TCR
expression
Phenotype upon
stimulation in vitro
TCR Tg –D H-2k or H-2k/b F1 5C.C7 a 1 b nil high normal
–D H-2b 5C.C7 a 1 b nil low “anergic”
OV H-2k 5C.C7 a 1 b nil high normal
CY H-2b 2B4 a 1 b nil low “anergic”
Ag Tg Y– or Z– – HELcyt – –
TCR 3 Ag Tg YD or ZD H-2k/b 5C.C7 a 1 b HELcyt low “anergic”268 Differential Avidity and T Cell Anergy In Vivo
tomed plastic plates (ICN Linbro), and incubated on ice in the
dark for 30 min. For sterile sorting, the depletion, staining and
washing steps were carried out in an aseptic manner. Data were
collected on a FACStarPLUS (Becton Dickinson) and analyzed
with WinMDI software (Scripps Research Institute, La Jolla,
CA). 2 3 105 events were routinely collected per sample.
Statistics
An unpaired Student’s t test was used to compare Va11 expres-
sion for double and single TCR Tg CD41 T cells. The geomet-
ric mean fluorescence channel number for 17 samples per group,
stained on the same occasion, was log transformed before deter-
mining the two tailed P value.
Results
Self-specific CD41 T Cells in Double Tg Mice Manifest an
Anergic Phenotype. The function of cells bearing the 5C.C7
TCR a and b chains was examined in vitro by comparing
the proliferative capacity of thymocytes and peripheral
lymphocytes from double (antigen 3 –D TCR) Tg with
that of –D TCR Tg mice. Both the number of responding
cells per well (Fig. 1 A) and the concentration of specific
peptide (Fig. 1 B) were titered. Thymocytes and lymph
node cells from double Tg mice responded to peptide with
a 10-fold lower incorporation of [3H]TdR than controls.
Addition of exogenous IL-2 restored the level of response
to that of controls, consistent with the original definition of
in vitro T cell anergy by Jenkins et al. (13). The incremen-
tal effect of exogenous IL-2 was greatest at low peptide
concentrations, when the amount of endogenous IL-2 pro-
duction would be at its lowest. When thymus and lymph
node cell suspensions were depleted of CD81 and HSA1
cells, the results were identical (data not shown), confirm-
ing that the proliferative response was attributable to ma-
ture CD41 cells.
Cytokine production was assessed in supernatants from
wells with the highest stimulating peptide concentration in
the experiment shown in Fig. 1 B. Supernatants from cul-
tures of double Tg cells contained z20-fold less IL-2 and
10-fold less IL-3 than the corresponding controls (Fig. 2),
again consistent with the classical phenotype of anergy in T
cell clones (for review see reference 15). When peptide-
dependent proliferation was augmented by addition of exog-
enous IL-2, secretion of IL-3 and IFN-g by double Tg cells
reached a level similar to that of controls (Fig. 2). Production
of IL-10, IL-5, and IL-4 was below the limit of detection
under these stimulation conditions (data not shown).
Exogenous IL-2 Recruits Double Tg Cells into Cell Division
in Response to MCC Peptide. To determine whether the
reduction in proliferation of double Tg T cells was due to
decreased proliferation per antigen-specific precursor, or to
a decrease in the number of precursors recruited into cell
division, the intracellular fluorescent label CFSE (31) was
used. CFSE-labeled, CD8-depleted thymocytes and lymph
node cells were cultured with various concentrations of
Figure 1. Thymus and lymph node T cells from double Tg mice man-
ifest an anergic phenotype in vitro. (A) Thymocytes and lymphocytes
were stimulated under four different stimulation conditions: 1 mM
MCC87–103 peptide with or without rhIL-2 at 50 U/ml, IL-2 alone, or
TCM alone. Four replicate cultures from each of four double and four
single TCR Tg H-2k/b mice were set up under each condition. Each
point represents the mean result for the 16 cultures and error bars repre-
sent the SEM. This result is representative of two experiments. (B) Prolif-
eration of thymocytes and lymph node cells in response to titered con-
centrations of MCC87–103 peptide. Each point represents the mean result
for four double or single TCR H-2k/b mice (16 cultures) and error bars
represent the SEM. Where error bars are not visible, they are too small to
be apparent. These data are also representative of two experiments. h,
TCM alone; s, IL-2; j, MCC peptide; d, MCC peptide plus IL-2.
Figure 2. Cytokine production by thymus and lymph node cells from
double versus TCR Tg mice. IL-2 was measured in supernatants from wells
stimulated with 10 mM MCC87–103 (from the experiment shown in Fig.
1 B). IL-3 was measured in the same supernatants and in the corresponding
wells to which additional rhIL-2 was added. IFN-g was measured in the
day 4 supernatants of cultures set up with 106 CFSE-labeled cells/ml and 10
mM MCC87–103 6 rhIL-2 (see Figs. 3 and 4 for CFSE profiles from these
cultures). IL-4, IL-5, and IL-10 were below the limit of detection in the
CFSE culture supernatants. Error bars represent the SEM for four individ-
ual mice in each group for IL-2 and IL-3 assays, and for duplicate IFN-g
ELISA assays of the CFSE culture supernatants. ND, none detected.269 Girgis et al.
MCC peptide, harvested on days 1, 2, 4, or 7 of culture,
and stained for cytofluorometric analysis. Data were gated
to identify live cells bearing the Tg-encoded specificity
(CD41Vb31Va111PI2). No division was seen on days 1
and 2 in cultures of either double or TCR Tg cells. By day 4,
the number of cells recruited into division was lower in
cultures containing double Tg cells (Fig. 3), although pro-
liferating cells from both double and TCR Tg mice had
undergone an equivalent number of divisions. The number
of cells recruited into division (i.e., the inverse of the num-
ber in the undivided peak) and the number of subsequent
divisions were both functions of peptide concentration in
cultures of double and TCR Tg cells. Cell death was not
responsible for the decrease in divided cell number in dou-
ble Tg cultures, as indicated by PI staining (data not
shown). Between days 4 and 7, the majority of TCR Tg
cells had undergone several further divisions, whereas the
fraction of divided cells had not increased substantially in
cultures of double Tg cells (data not shown).
When saturating doses of rhIL-2 (50 U/ml) were added
to peptide-stimulated cultures of CFSE-labeled thymus and
lymph node cells, division of TCR Tg cells was un-
changed, whereas recruitment of cells into division in cul-
tures of double Tg cells was increased to a level comparable
with that of the TCR Tg controls (Fig. 4). Despite the
higher total number of divided cells, the pattern of division
was unaffected by addition of IL-2 (see Discussion). In ad-
dition, no divisions occurred on the first 2 d of culture
even in the presence of saturating IL-2. The day 7 profiles
showed that cultures of cells from both TCR and double
Tg mice continued to divide in an equivalent manner in
the presence of exogenous IL-2 (data not shown).
Figure 3. CFSE division profile of
CD41Va111 thymus and lymph node cells
after in vitro stimulation with MCC peptide
in the absence of exogenous IL-2. Thymus
and lymph node cell suspensions from dou-
ble and TCR Tg donor mice were depleted
of CD81 cells, labeled with CFSE, and cul-
tured with a titration of MCC87–103 peptide
in the presence of a constant number of
syngeneic irradiated APCs. Wells with no
additional peptide were included as con-
trols. No cell division was seen on days 1
and 2 (data not shown). Histograms of
CFSE fluorescence intensity were gated for
CD41Vb31Va111PI2 cells and are shown
for cultures harvested on day 4. By day 7,
the vast majority of TCR Tg cells had en-
tered division, and many had proliferated
such that their CFSE signal was too low to
be distinguished from the autofluorescence
of activated T cells (.8 divisions). In con-
trast, no further division of double Tg cells
was seen between days 4 and 7. The data are
representative of three experiments.
Figure 4. CFSE division profile of CD41
Va111 thymus and lymph node cells after in
vitro stimulation with MCC peptide and
exogenous IL-2. Cultures were set up as for
Fig. 3, with addition of rhIL-2 (50 U/ml).
Analysis of day 4 CFSE division profiles
was performed by gating on CD41Vb31
Va111PI2 cells. Once again, no cell division
was seen on days 1 and 2 (data not shown).
By day 7, the majority of cells in cultures of
TCR and double Tg cells had divided at
least eight times (the level at which CFSE
reaches the level of autofluorescence for ac-
tivated T cells). The data are representative
of three experiments.270 Differential Avidity and T Cell Anergy In Vivo
Reduced Expression of Tg-encoded TCR a But Not b Chain
by CD41 T Cells in Double Tg Mice. Analysis of Tg-encoded
Va11 and Vb3 expression by mature CD41 thymus and
lymph node cells directly ex vivo showed a small but sig-
nificant (P , 0.0001) reduction in Va11 levels on double
Tg cells in comparison to control cells (Fig. 5 B, top),
whereas the levels of Vb3 (Fig. 5 B, bottom) and CD4 (Fig.
5 A) were identical to that of controls. This suggested that
the proportion of mature CD41 Tg cells expressing dual
TCR a chains increases significantly in the presence of
cognate self-antigen. The CD44 profile was identical in the
polyclonal CD41Tga2 populations from double and TCR
Tg mice, whereas the percentage of CD44hi cells within
the CD41Tga1 population of double Tg mice was mar-
ginally higher than in single Tg controls (Fig. 5 C).
In vitro stimulation revealed an incidental finding under-
lining the functional consequences of small initial differ-
ences in the level of expression of the 5C.C7 TCR by
CD41 cells from double and TCR Tg donors. Division-
dependent downregulation of the 5C.C7 TCR caused dou-
ble Tg CD41 cells to reach baseline levels prematurely,
when compared with TCR Tg controls (Fig. 5 D). Cultures
stimulated with peptide and IL-2 were chosen for analysis in
order to provide adequate numbers of cells at each division,
and cells were gated for IL-2R1 to exclude cells whose ini-
tial expression of the 5C.C7 a chain was too low to mediate
a response to MCC peptide. Va11 expression by IL-2R1
cells was reduced sequentially at each cell division, suggest-
ing that antigen-mediated TCR internalization occurred at
each cell division (44) and/or that de novo synthesis was in-
sufficient to maintain a constant level of expression in
daughter cells. The 50% reduction in average Va11 expres-
sion by double Tg cells before stimulation resulted in a rapid
decline to undetectable TCR levels after four cell divisions,
whereas Tg TCR-a expression on control cells was re-
duced by only half after the same number of divisions.
Double and TCR Tg Cells Show Equivalent Responses to
Staphylococcal Enterotoxin A in the Absence of Exogenous IL-2.
Since cells from double Tg mice expressed reduced num-
bers of 5C.C7 TCRs specific for cytochrome c, it was
possible that their hyporesponsive state was simply the re-
sult of low avidity for MCC peptide, rather than represen-
tative of an induced biochemical change secondary to prior
recognition of antigen. To distinguish between these possi-
bilities, the response of double and TCR Tg cells to a Vb3-
mediated stimulus, staphylococcal enterotoxin A (SEA),
was compared, since double Tg cells expressed the same
number of Tg-encoded 5C.C7 Vb3 chains as controls.
Thymus and lymph node cell suspensions depleted of
CD81 and HSA1 cells were CFSE-labeled and stimulated
in vitro with SEA or MCC peptide. Although the charac-
teristic difference in peptide response was seen (data not
shown), the CFSE profiles generated in response to stimu-
lation with SEA were identical for CD41Vb31Va111 cells
from either double or TCR Tg T cells (Fig. 6), and for
CD41Vb31Va111 cells and CD41Vb31Va112 cells within
each culture (data not shown). In addition, the amount of
IL-2 detected in cell culture supernatants was equivalent at
each concentration of SEA (data not shown).
To exclude the possibility that Vb31Va112 cells may
have acted as a source of IL-2 for Va111 cells in cultures of
double Tg cells, CD41Va111 and Va112 cells were sorted
from thymocyte suspensions derived from double and
TCR Tg donors, CFSE labeled, and stimulated in vitro
with 100 ng/ml SEA. In this case 100% of CD41 cells up-
regulated IL-2Ra in response to superantigen and the day 3
CFSE division profiles were identical in all cultures (Fig. 7
A). Culture supernatants also showed comparable cytokine
profiles, with detection of equivalent amounts of IFN-g,
IL-4 (Fig. 7 B), IL-2, and IL-3 (data not shown). No IL-10
secretion was detected (data not shown). These data show
that there is no intrinsic defect in cells from double Tg
mice and that they are able to respond normally to TCR-
mediated stimuli of sufficient avidity.
Naive T Cells with Low Tg TCR-a Expression Also Mani-
fest an Anergic Phenotype In Vitro. The above data sug-
gested that the anergic phenotype of CD41 self-specific
Figure 5. Expression of TCR, CD4, and CD44 in double and TCR
Tg mice. (A) 5C.C7 TCR expression by CD41 cells in the lymph nodes
of double and TCR Tg mice. (B) Reduction in the level of Tg a but not
Tg b expression by CD41CD82 cells in the thymus and lymph nodes of
double Tg mice (filled profiles) as compared with TCR Tg controls (un-
filled profiles). (C) CD44 expression by Tga1 versus a2 subsets of double
and TCR lymph node CD41 cells. (D) Response of double and TCR Tg
cells to in vitro stimulation by 1 mM MCC87–103 peptide and 50 U/ml
rhIL-2. Day 3 profiles were gated for IL-2R1 cells (left). A minor differ-
ence in the initial efficiency of CFSE labeling accounts for the difference
in the absolute intensity of the CFSE profiles. Further gating for each
CFSE division peak was performed according to the gates shown in the
left panels, yielding the Va11 profiles in the center panels. (Right) The
line graph represents the geometric mean fluorescence intensity of Va11
at each division for two mice in each group. h, TCR Tg; s, double Tg.
These data are representative of six in vitro experiments involving stimu-
lation with either peptide 6 IL-2 or SEA.271 Girgis et al.
cells may have resulted from the reduced number of TCRs
available for specific ligand binding. To examine whether
naive CD41 T cells expressing dual a chains also mani-
fested an anergic phenotype in vitro, a number of TCR Tg
lineages were compared (see Table I and Fig. 8). To in-
crease the frequency of cells expressing dual a chains, TCR
Tg mice expressing either the 5C.C7 (–D) or 2B4 (CY;
reference 26) TCRs were bred onto a congenic H-2b
background, in which the Tg-encoded specificity was not
positively selected. Thus any Tg a1b1 cells reaching the
periphery were selected via a second, endogenously rear-
ranged a chain. Comparison of Tg-encoded a with b ex-
pression confirmed that the majority of cells in such mice
showed significantly less Va11 staining (Fig. 8, top two
rows), but that Vb3 was expressed at control levels (data not
Figure 6. CFSE division profile of
CD41CD82Va111 thymus and lymph node
cells after in vitro stimulation with SEA in
the absence of exogenous IL-2. Histograms
of CFSE fluorescence intensity, gated on
CD41Vb31Va111PI2 cells, are shown for
day 3 cultures. The profiles are representa-
tive of two experiments.
Figure 7. Response of sorted CD41CD82Va111 thymus cells to in
vitro stimulation with SEA in the absence of exogenous IL-2. CD8-
depleted thymocytes from double and TCR Tg mice were sorted into
CD41PI2Va111 and Va112 subsets before CFSE-labeling and cultured
with syngeneic irradiated APCs and 100 ng/ml SEA. Histograms of CFSE
fluorescence intensity show equivalent cell division profiles from all
sorted subsets of cells on day 3. In addition, 100% of CD41 cells upregu-
lated IL-2Ra in each culture (data not shown). Similar findings were
achieved with lymph node cells (data not shown). (B) Cytokine produc-
tion by SEA-stimulated sorted cells from the experiment shown in A,
measured in day 3 culture supernatants. dark gray bars, double Tg; light
gray bars, TCR Tg.
Figure 8. Naive T cells of low avidity manifest an anergic phenotype
in vitro. Left panels show representative overlay histograms of Va11 ex-
pression, stained directly ex vivo, from a number of Tg mouse lines (filled
histograms) compared with a 2D H-2b/k control stained on the same oc-
casion (unfilled histograms) (see Table I for a description of the Tg lines).
Right  panels show the in vitro proliferative response as assessed by
[3H]TdR incorporation from cultures of thymus and lymph node cells
stimulated with MCC87–103 with and without rhIL-2, IL-2 alone, and
TCM alone, as indicated. h, TCM; s, IL-2; j, MCC peptide; d,
MCC peptide plus IL-2.272 Differential Avidity and T Cell Anergy In Vivo
shown). They also expressed low levels of CD44, indica-
tive of a naive phenotype. Thus, for example, the percent-
age of CD44hi cells within the CD41Tg a1b1 compart-
ment of –D H-2b mice was 1.45 6 0.04%, compared with
1.16 6 0.62% for –D H-2k/b mice. CD41Tg a2b1 cells
from the same donors contained a mean of 3.94 6 0.38
and 6.45 6 1.65% CD44hi cells respectively. The CD44
data for the CY line on an H-2b background were similar
(Fazekas de St. Groth, B., unpublished data). An anergic
phenotype in response to peptide was apparent even
though the cells had not been exposed to their cognate an-
tigen in vivo (Fig. 8). In contrast, OV Tg mice on an H-2k
background expressed Tg-encoded Va11 at levels compa-
rable with –D H-2k/b controls and showed no augmenta-
tion of peptide-dependent proliferation in response to ex-
ogenous IL-2. This example provides further evidence that
the anergic phenotype seen here in vitro is a function of the
level of Tg-encoded TCR expression, independent of the
particular line of Tg mice from which the cells are derived.
Discussion
The studies presented here describe a double Tg model
of CD41 T cell self-tolerance induced in the thymus in re-
sponse to a conventionally processed soluble protein anti-
gen. In contrast to other published studies in which in-
trathymic recognition of antigen led to complete deletion
of developing self-reactive T cells (45), low level expres-
sion of the HELcyt neo-self-antigen allowed a proportion
of self-specific cells to escape deletion in the thymus and
periphery (22, 23). Consistent with the suggestion that low
avidity was responsible for escape from deletion, a small but
significant reduction in expression of Tg-encoded a but
not b chain was detected in residual cytochrome-specific
thymic and peripheral CD41 T cells (Fig. 5). This pheno-
type, indicative of expression of more than one a chain,
has been described previously in several TCR Tg models
(46–48) and is known to reduce the avidity for specific an-
tigen, in comparison to cells expressing normal numbers of
Tg-encoded a/b pairs (49). Since the dual a, self-specific
cells failed to cause autoimmunity in vivo and were hypo-
responsive to specific antigen in vitro (22), they provided a
unique opportunity to examine nondeletional mechanisms
of tolerance in low avidity, self-reactive CD41 T cells.
Expression of dual a chains by residual self-specific cells
was associated with an anergic phenotype after peptide stimu-
lation in vitro, as defined by a decrease in lymphokine pro-
duction and proliferation per antigen-specific precursor, re-
versible on addition of exogenous IL-2 (Figs. 1 and 2). This
phenotype was also seen in response to stimulation of naive,
dual a–expressing cells from TCR Tg mice (Fig. 8). These
data suggest that the anergic phenotype may simply represent
the response of low avidity primary cells (the selective
model), rather than being the result of repeated low level
stimulation in the thymus or periphery (the inductive model).
Several further approaches were used in an attempt to
determine whether the anergic phenotype in double Tg
animals was best explained by the selective or inductive
models. Although the number of self-specific Tg-encoded
a/b pairs expressed by anergic cells was reduced, the total
number of b chains (and therefore of TCRs) was equal to
the number expressed by naive T cells (Fig. 5 B). Thus the
pattern of TCR expression was inconsistent with the
changes normally associated with recognition of antigen,
namely downregulation of the entire TCR complex via in-
ternalization and degradation (44, 50). In addition, cells
from double Tg mice did not manifest the small constitu-
tive decline in total TCR and CD4 levels (Fig. 5 A) char-
acteristic of activated and memory T cells (51).
As a further means of distinguishing between the induc-
tive and selective models of anergy induction, cells from
double Tg mice were tested for hyporesponsiveness to an
antigen different from that to which they had been exposed
in vivo. The superantigen SEA was chosen because it is
known to be recognized by TCRs using the 5C.C7 Vb3
chain (52), which is expressed at a normal level on 100% of
anergic and control cells. The inductive model would pre-
dict that downstream TCR signaling would be altered in
anergic cells, and hence the response to any TCR-medi-
ated signal should be affected, whereas the selective model
would predict a normal response dependent solely on the
high avidity of interaction. The responses of cells from
double and control TCR Tg mice to SEA were indistin-
guishable, both being characterized by a normal CFSE di-
vision profile (Fig. 6). Sorting of CD41Tg b1a1 cells indi-
cated that anergic cells were capable of secreting the same
levels of cytokines as control cells in response to SEA (Fig.
7). Thus, the residual self-reactive cells in double Tg mice
are not intrinsically unresponsive, nor are they impaired in
their ability to produce IL-2 given a TCR stimulus of suffi-
cient avidity.
Our data are thus consistent with the view that a reduc-
tion in the number of antigen-specific TCRs accounts for
the anergic phenotype in vitro. A twofold reduction in
TCR number has previously been shown to exert a pro-
found effect on proliferation in vitro (49, 50) via premature
termination of serial triggering and degradation of TCRs
(50). This interpretation is also consistent with the charac-
teristically tight peak of surface TCR expression by periph-
eral T cells, in contrast to most other T cell surface mole-
cules apart from CD4, another molecule closely involved
in binding to antigen–MHC complexes.
An incidental finding that underlined the consequences
of the small initial reductions in specific TCR levels was
the progressive decline in TCR levels with cell division in
anergic and control cells (Fig. 5 D). Such a mechanism
would be predicted to curtail the T cell response to further
stimulation by antigen, and its exaggeration in the case of
anergic cells provides a graphic illustration of the effect of
reduction in the level of Tg-encoded TCR-a/b on the
ability to mount a prolonged in vitro response. However, it
should be noted that TCR levels do not show a division-
related decline after in vivo stimulation of either anergic or
control cells (Girgis, L., and B. Fazekas de St. Groth,
manuscript in preparation). Our data do not answer the
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peated antigen recognition and TCR internalization at each
cell division or by a failure to synthesize sufficient TCR to
maintain the level on daughter cells. The effect on division-
related TCR levels of removal of antigen after initial activa-
tion in vitro should provide an insight into this question.
CFSE labeling revealed that the decrease in proliferation,
as detected by [3H]TdR incorporation (Fig. 1) was due to a
decrease in the total number of divided cells in cultures
from double Tg donors, although the distribution of di-
vided cells within the CFSE profile was the same for cul-
tures of double and TCR Tg cells at each peptide concen-
tration (Fig. 3). Differential cell death was excluded as a
cause of the reduction in the number of divided cells by
three approaches: a proportionate increase in the number
of undivided cells, evident particularly at high peptide con-
centrations, in the cultures of cells from double Tg mice
(Fig. 3), viable cell counts (data not shown), and PI exclu-
sion during flow cytometry (data not shown).
Upon addition of exogenous IL-2, the CFSE profiles of
double Tg cells indicated further recruitment of peptide-
responsive precursors into division (Fig. 4). Anergic cells
thus produce insufficient IL-2 to recruit all the cells that
have upregulated IL-2R in response to antigen. By con-
trast, exogenous IL-2 had no effect on cell division in con-
trol cultures, indicating that TCR Tg cells produce suffi-
cient endogenous IL-2 to drive cell division at its maximal
peptide-dependent rate. Since addition of IL-2 changes the
total number but not the CFSE distribution of divided cells
in cultures of double Tg cells (Figs. 3 and 4), the rate-limit-
ing step at suboptimal concentrations of IL-2 is recruitment
into cell division, rather than progression to further divi-
sion. Thus, our data indicate either that further cell division
is not IL-2 dependent or, more likely, that the amount of
IL-2 required to maintain division is relatively small in
comparison to the amount required for the first division.
The latter interpretation is also supported by comparison of
the CFSE profiles for cultures of double and TCR Tg cells
at day 7 (data not shown), in which division of double Tg
cells ceased prematurely, whereas addition of IL-2 allowed
the cells to continue to divide at the same rate as controls.
Recent evidence has suggested that the critical variable
affecting the distribution of T cells within the cell division
profile is the time to first division, the rate of subsequent
division being constant in the presence of adequate con-
centrations of growth factor (53). As mentioned above, IL-2
availability controls recruitment into division but not the
shape of the division profile. In contrast, the cell division
profiles (excluding undivided cells) reveal a role for peptide
concentration, such that the average number of divisions
decreases as peptide concentration decreases, even in the
presence of saturating concentrations of IL-2 (Fig. 4). This
indicates that peptide concentration controls the response
to IL-2 via the expression of IL-2R. Thus the CFSE pro-
files reveal dissociation of two downstream effects of TCR
ligation: IL-2R expression and IL-2 production. Only IL-2
production is affected in anergic cells, suggesting that a
twofold decrease in TCR number is crucial for the produc-
tion of IL-2 but not IL-2R. Published studies have indi-
cated that IL-2R expression has a Ca21-independent com-
ponent and is principally a function of NF-kB translocation
(54), whereas IL-2 production requires a prolonged Ca21
flux (55–57). Thus, dissociation of TCR-induced expres-
sion of IL-2 and IL-2R in anergic cells is consistent with
currently accepted concepts of diverse downstream TCR-
dependent signaling pathways.
One possible explanation of this finding is based on Lan-
zavecchia’s model of serial TCR triggering in which TCRs
are internalized and degraded after binding peptide–MHC
(44, 50). Upon initial contact with antigen, when the num-
ber of antigen-specific TCRs would be very much in ex-
cess of the number of peptide-MHC complexes, a twofold
decrease in antigen-specific TCR number would have little
effect on signaling. However, as internalization and degra-
dation of antigen-specific TCRs proceeded, their relative
representation as a proportion of total TCRs would decline
rapidly in cells expressing more than one TCR a chain.
Since TCR signaling appears to require formation of oligo-
mers of TCR-peptide–MHC complexes (58, 59), signaling
would be curtailed prematurely as unligated TCRs of the
wrong specificity interfered with the formation of stable
oligomers. By contrast, in cells expressing only one speci-
ficity of TCR-a/b heterodimer, signaling would continue
until the absolute concentration of TCRs was too low to
allow efficient oligomerization.
Correlation of IL-2R expression with peptide concen-
tration, and of IL-2 production with initial antigen-specific
TCR number, thus implies that IL-2R expression is closely
related to the magnitude of the early TCR-mediated sig-
nals, whereas IL-2 production is crucially dependent upon
the duration of signal. This explanation is consistent with
the selective model, in that a twofold decrease in TCR ac-
counts for the anergic phenotype without the necessity of
invoking biochemical changes. A second possibility, consis-
tent with the inductive model, is that the two arms of
TCR signaling are differentially affected by induction of
anergy, such that only IL-2 production is targeted. How-
ever this explanation is inconsistent with the data regarding
the response of naive dual TCR a chain cells to in vitro
stimulation (Fig. 8).
Restoration of IL-3 and IFN-g production to control
levels upon addition of exogenous IL-2 (Fig. 2) is consis-
tent with recent evidence that cytokine production is a
function of cell division–dependent differentiation (53).
Thus, the effect of exogenous IL-2 is to restore the number
of cells at each division to control levels, allowing a normal
number of cells to progress to cytokine production with a
division-dependent probability.
The vast majority of self-specific tolerant cells in our
double Tg mice express CD44 at levels consistent with a
naive phenotype, once again providing support for the se-
lective model (Fig. 5 C). Priming by environmental anti-
gens probably accounts for the small percentage of CD44hi
cells within the dual a population, since such cells would
be expected to express a polyclonal repertoire of TCRs
containing endogenous a chains. The level of CD44 ex-
pression in this population is similar to that in the poly-274 Differential Avidity and T Cell Anergy In Vivo
clonal CD41Tga2 populations of both double and TCR
Tg mice. Consistent with this interpretation, the CD41
Tga1 population from TCR Tg mice, which is not subject
to negative selection in the thymus and therefore contains a
higher proportion of cells expressing only the Tg-encoded
a chain, contains very few CD44hi cells (Fig. 5 C).
In contrast, in some models of peripheral T cell tolerance
induction tolerant cells express high levels of CD44, in-
dicative of chronic activation (60, 61). In the study of Ak-
karaju et al. (61), peptide-specific CD41 T cells were ex-
posed to a soluble neo-self-antigen in both thymus and
periphery, and residual peripheral T cells had upregulated
CD44 and downregulated both chains of the TCR, sug-
gestive of a response to peripheral antigen after leaving the
thymus. Similarly, unresponsiveness also appeared to have
been induced in the periphery in the model of Blackman et al.
(62, 63). The mechanism of self-tolerance thus appeared to
be different from the double Tg model described here. In
addition, high levels of IL-10 production by anergic cells
have been noted in a number of studies (64–67), although
in others naive cells stimulated in the presence of IL-10 be-
came anergic without producing IL-10 themselves (68).
Since IL-10 is one of the last cytokines to be produced by
differentiating CD41 T cells (53, 69, 70), IL-10–producing
anergic cells may have been primed via continuous expo-
sure to a low avidity stimulus (14, 20, 71), analogous to the
conditions under which the cells responsible for infectious
tolerance are primed (72). Induction of IL-10 under these
circumstances is best explained by the inductive rather than
selective model of anergy. The use of the term anergy in
such diverse cases underlines the difficulties with the current
terminology, since it currently covers naive cells, terminally
differentiated Th2 cells, and those that have undergone in-
duction of “classical” anergy (11) via TCR stimulation.
Peripheral expression of self-specific TCR a chains at a re-
duced level per cell has also been noted in class I–restricted
TCR Tg models in which high avidity CD81 T cells are
deleted in the thymus (73, 74). The residual cells manifest a
phenotype termed “split tolerance”, in which the cells are
functionally tolerant in vivo but reactive in vitro. Since in
vitro stimulation of CD81 T cells in these studies was per-
formed in the presence of exogenous IL-2 to compensate
for the lack of CD41 T cell help, it is unclear whether such
self-tolerant CD81 T cells are analogous to anergic CD41
T cells. However, previous studies of split tolerance in
polyclonal CD81 T cell populations suggested that such
cells are indeed specifically unresponsive in vitro in the ab-
sence of exogenous IL-2 (75). Thus, the mechanism of tol-
erance in these models of partial thymic deletion is also
consistent with the selective model. In several cases, pe-
ripheral rather than thymic tolerance in class I–restricted
TCR Tg models also appears to result from selective dele-
tion of high avidity cells, leaving a residual population of
dual a T cells (7, 76, 77).
Here, we have shown in a double TCR Tg model that
the presence of a neo-self-antigen in the thymus can cause
the appearance of peripheral T cells with reduced Tg
TCR-a expression and an anergic phenotype. We hypoth-
esize that the reduction in avidity secondary to low expres-
sion of antigen-specific TCRs leads to reduced responsive-
ness and in vivo tolerance. A second means of producing
low avidity TCR stimulation is the use of low affinity al-
tered peptide ligands, which also generate an anergic phe-
notype by upregulating IL-2R in the absence of optimal
IL-2 production (14). Since the anti–self-repertoire is likely
to have been purged of high affinity cells in the thymus
(78), the peripheral self-reactive population may be in a
functional state analogous to that of the anergic double Tg
cells in our study, as demonstrated in normal individuals
(79). The in vivo regulation of such low avidity cells after
challenge with self-antigen will provide a novel and impor-
tant model of autoimmune regulation.
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